Search

  • HOME
  • Search
1884
Steatotic liver disease: Know your enemies
Lung-Yi Mak
Clin Mol Hepatol. 2024;30(2):171-173.   Published online February 2, 2024
View: 2738   Download: 95  Web of Science: 1  Crossref: 3
Review
1737
Screening strategy for non-alcoholic fatty liver disease
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Clin Mol Hepatol. 2023;29(Suppl):S103-S122.   Published online November 30, 2022
View: 6257   Download: 267  Web of Science: 19  Crossref: 19
1764
The role of different viral biomarkers on the management of chronic hepatitis B
Lung-Yi Mak, Rex Wan-Hin Hui, James Fung, Wai Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2023;29(2):263-276.   Published online January 19, 2023
View: 6517   Download: 342  Web of Science: 17  Crossref: 15
1758
Clinical practice guidelines and real-life practice on hepatocellular carcinoma: A the Hong Kong perspective
Rex Wan-Hin Hui, Lung-Yi Mak, Tan-To Cheung, Victor Ho-Fun Lee, Wai-Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2023;29(2):217-229.   Published online December 28, 2022
View: 7010   Download: 260  Web of Science: 12  Crossref: 14
Correspondence
Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2023;29(1):191-193.   Published online November 22, 2022
View: 3415   Download: 74
Original Article
1700
Hepatitis B virus pre-genomic RNA and hepatitis B core-related antigen reductions at week 4 predict favourable hepatitis B surface antigen response upon long-term nucleos(t)ide analogue in chronic hepatitis B
Lung-Yi Mak, Danny Wong, Alison Kuchta, Martina Hilfiker, Aaron Hamilton, Ning Chow, XianHua Mao, Wai Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2023;29(1):146-162.   Published online August 19, 2022
View: 6795   Download: 242  Web of Science: 18  Crossref: 15
Review
1664
RNA interference as a novel treatment strategy for chronic hepatitis B infection
Rex Wan-Hin Hui, Lung-Yi Mak, Wai-Kay Seto, Man-Fung Yuen
Clin Mol Hepatol. 2022;28(3):408-424.   Published online February 17, 2022
View: 10236   Download: 678  Web of Science: 49  Crossref: 56
Prospect of emerging treatments for HBV functional cure
Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, Wai-Kay Seto, Man-Fung Yuen
Received September 29, 2024  Accepted November 14, 2024  
View: 1232   Download: 252  Crossref: 1
Review Article
Mechanisms of HCC and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Received September 25, 2024  Accepted November 16, 2024  
View: 904   Download: 95
Original Article
Longitudinal profile of plasma pregenomic RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues and its interaction with clinical parameters
Lung-Yi Mak, Mark Anderson, Michael Stec, Matthew Shing-Hin Chung, Danny Ka-Ho Wong, Rex Wan-Hin Hui, Wai-Kay Seto, Gavin Cloherty, Man-Fung Yuen
Received August 27, 2024  Accepted December 21, 2024  
View: 516   Download: 50
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1065
TOTAL : 2469144
Close layer